Hercules Capital, Inc. HTGC

Hercules Capital has delivered a strong multi year share price run, yet the real question for investors is whether that market performance lines up with the returns it earns on its capital. With the stock now trading around recent levels, the issue is how much of Hercules Capital's capital efficiency is already reflected in the current price. Over the past 5 years, Hercules Capital has returned 78.8%. This puts the spotlight on whether the underlying returns on its investment portfolio and...

Hercules Capital trades at $16.95 and has moved in lockstep with the market. Its shares have returned 19.4% over the last six months while the S&P 500 has gained 22.1%.

Hercules Capital (HTGC) has a fresh governance catalyst. The business appointed Alfred B. Fichera as an independent director and Audit Committee member on 17 September 2026, bringing extensive audit and asset management experience. Hercules Capital’s share price has softened in the short term, with the 30-day share price return down 3.26% and the year-to-date share price return down 10.34%. In contrast, the 1-year total shareholder return is slightly positive at 0.58% and the 5-year total...

BELOIT, Wis., September 29, 2026--NorthStar Medical Technologies, LLC (NorthStar), the first commercial-scale producer of no-carrier-added actinium-225 (n.c.a. Ac-225) using electron-accelerator technology, today announced a multi-year growth capital facility of up to $185 million with Hercules Capital, Inc. (NYSE: HTGC) to support NorthStar’s continued growth and expansion. The financing, including $100 million upfront, will accelerate investment in isotope production and in clinical and commer

The yield you choose determines whether you need $900,000 or over $3 million to hit the same income target, and picking the wrong tier can leave your purchasing power shrinking every year even while the checks keep arriving.

The yield you chase determines not just how much capital you need, but whether your income quietly erodes over time or quietly grows. The right answer is less obvious than most retirees assume.

Looking back on specialty finance stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Hercules Capital (NYSE:HTGC) and its peers.

SAN MATEO, Calif., September 17, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Alfred B. Fichera was appointed to serve as an independent member of its board of directors, effective September 17, 2026. Mr. Fichera is an expe

The capital required to replace a professional salary with investment income swings by more than $2 million depending on one decision, and most investors default to the wrong tier without realizing it.

Retirees chasing cash flow face a brutal tradeoff between yield and safety, but a carefully chosen mix of net-lease REITs and a venture lender can tip that balance in surprising ways.

Hercules Capital has delivered a powerful 87.8% total return over the past 5 years, yet its current US$17.64 share price raises a sharper question for you as an investor. Are those past gains and the business it has built enough to justify today's valuation when you focus squarely on the returns it earns on its capital? The 87.8% return over 5 years puts real weight on whether Hercules Capital's underlying return on its own capital can support the price level the market is now...

A seven-holding portfolio promising $12,500 a month sounds straightforward until you examine whose money is actually funding some of those distributions, and why the highest-yielding positions have the weakest claim to keeping their promises.

SAN MATEO, Calif., September 09, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty finance provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Hercules Adviser LLC ("Hercules Adviser"), its wholly-owned registered investment adviser, has surpassed $2.3 billion in investable capital. The mi

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.